Men often face higher percentages of diseases and mortality, but women show better care results. This global review reveals where health systems achieve and fail throughout the gender gap.
Study: Data prepared by sex along the gender health paths: a review and analysis of global data on hypertension, diabetes, HIV and AIDS. Credit Picture: Shutterstock
In a recent article published in the magazine Drug plosResearchers have found that gender differences in burden, access and results are complex and vary by country, state and stage of health road. In many contexts, males face an overweight of increased prevalence of diseases and risk factors and lower access to diagnosis and treatment.
The results of sex and sex health through various factors, including health care standards, physical reactions to the exposure at risk, and exposure rates to environments and risk factors. Understanding the differences in health results, the risk exposure and the use of the Health Service by gender identity and sex could help identify effective interventions to reduce health inequalities. However, gender identity and gender are often combined and confused with health research.
Consequently, the analysis of research data becomes provocative. In addition, only a few surveys report gender identity beyond the simple binary (male/female). Data disconnecting along a health pathway (from death -to -risk exposure, including the prevalence of diseases and care cataracts) could provide a systematic and holistic view of health inequalities and gender and gender and detecting opportunities for customized interventions.
For the study
The researchers have analyzed the data made from sex from worldwide surveys and databases, interpreting the observed differences through a lens that has informed the sex. While the data sets themselves were gender separated (male/female), the authors acknowledged that the data could not fully distinguish biological and social influences. The study examined eight health conditions, but had sufficient care of waterfalls for only three: HIV/AIDS, hypertension and diabetes. The prevalence of diseases, risk factors and mortality data came from the global weight of all diseases.
Risk factors for HIV/AIDS and diabetes were selected on the basis of the global mortality burden, with age and gender data. For hypertension, the top cardiovascular risk factors were used. Care cataracts included diagnosis, treatment and disease control. Data sources included the cooperation of the NCD (hypertension) risk factor, the gradual approach to monitoring the NCD risk factor (diabetes) and UNAIDS (HIV/AIDS). Some elements were collected as “spatial years”, where countries have contributed to many years of observations.
Findings
Data prepared by sex on risk factors, prevalence of diseases and mortality were available for all three conditions in 204 countries. However, Cascade Care data varies: hypertension (200 spatial years), diabetes (39) and HIV/AIDS (76).
Hypertension risk factors included high sodium intake, high fasting plasma glucose (FPG), smoking, obesity and overweight. Males had significantly higher smoking rates in 176 countries (other than Boutan), while obesity rates were higher in women in 130 countries. Excessive dominance was largely similar between gender.
Illustration of Health Road.
The prevalence of global hypertension was comparable, with exceptions in eight countries where males had a higher prevalence. India showed higher hypertension in women aged 70-79 years. There were no significant worldwide sex differences in the hypertension waterfall, although some countries had higher rates of diagnosis or treatment among women in specific age groups.
In Uzbekistan, Iran and Peru, women aged 30-39 had higher hypertension control rates. The rates of mortality of male hypertension were higher in 107 countries, especially in countries of high and upper average income. Regional differences occurred in all diseases – for example, male deaths from HIV/AIDS and diabetes were more common in Europe, Central Asia and Latin America, while the highest deaths of women occurred in the Middle East and North Africa.
Diabetes risk factors included FPGs, use of insulin/drugs, overweight, obesity, smoking and low physical activity. Natural inactivity was similar between gender, although some countries showed differences. The prevalence of diabetes varies: higher in men in 61 countries and women in 10. Diabetes mortality was higher in men in 100 countries and in women in 9, with 95 countries not showing a difference.
For HIV/AIDS, risk factors included drug use, unsafe sex and violent violence. Drug use was higher in men in 139 countries and in females in a few (eg, Syria, China, Iceland). Incissible sex was more common among women in 113 countries. The prevalence of HIV was higher in men in 114 countries and in women at 28, HIV Care Care Data showed better results for females in 9, 20 and 21 countries (diagnosis, treatment and control, respectively). Lebanon was an exception, with males better to treat treatment and control. HIV/AIDS deaths were higher in men in 131 countries and women at 25.
Conclusions
The findings reveal significant gender differences along the health road. In many countries, males have a higher prevalence and mortality of diseases and lower treatment and treatment adhesion rates. However, the differences in care of care were less consistent and more limited than those of the burden of diseases and risk factors.
The study warns that biological sex is not the only guide of these differences – social standards, health system structures, geography and policies also play an important role. Restrictions include incomplete data sets for many conditions and countries, under -representation of non -binary individuals and marginalized populations and inconsistent definitions in all surveys.
Researchers require more comprehensive and standardized global data, which are separated by age, gender and other cross -sectoral factors such as income, location, nationality and disability. Without such data, the ability to design gender interventions is limited.
In the end, the study emphasizes the need for cross -sectional data for the development of more fair health and intervention policies worldwide.
